Eric Przybyszewski

7PUBLICATIONS

16CO-AUTHORS

Predictive and prognostic markersMolecular targetsCardiology (incl. cardiovascular diseases)Medical virologyField theory and string theory

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (7)

Sort by Publication Date:

|May 12, 2026

Glucagon-Like Peptide-1 Receptor Agonist Use and Liver-Related Outcomes in Metabolic Dysfunction-Associated Steatotic Liver Disease and Type 2 Diabetes in the All of Us Research Program.

|Dec 16, 2025

Association of Sodium-Glucose Cotransporter-2 Inhibitors With Reduced Hepatocellular Carcinoma Risk in Patients With Type 2 Diabetes.

Jonggi Choi, Vy H Nguyen, Eric Przybyszewski

|Apr 16, 2024

Letter to the Editor: On the use of nonselective beta-blockers in cirrhosis.

Eric M Przybyszewski, Irun Bhan, Joseph C Yarze

|Mar 29, 2024

A natural language processing algorithm accurately classifies steatotic liver disease pathology to estimate the risk of cirrhosis.

Marc S Sherman, Prasanna K Challa, Eric M Przybyszewski

|Nov 08, 2023

In a tight spot.

Eric M Przybyszewski, Daniel S Pratt

|Sep 13, 2023

Unmet Needs in the Post-Direct-Acting Antiviral Era: Hepatocarcinogenesis After Hepatitis C Virus Eradication.

Eric M Przybyszewski, Raymond T Chung

Pageof 2

Frequent Collaborators

Erik Almazan

Tracey G Simon

Jiunn Song

Vy H Nguyen

Jonggi Choi

Marc S Sherman

Robert M Wilechansky

Timothy Gilbert

Keli Santos-Parker

Emily Bethea

Frequent Collaborators

Erik Almazan

Tracey G Simon

Jiunn Song

Vy H Nguyen